| Pharmaceutical active ingredients: |
| Flunisolide |
| Available forms, composition and doses of Syntaris: |
| Solution; Oral; Flunisolide 0.25 mg / ml |
| Syntaris medical category: |
| Human:Anti-inflammatory agentsCorticosteroids |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| R01AD04 - FlunisolideR03BA03 - Flunisolide |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| RocheDermapharmIVAXRecordati |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Synsac | Fluocinolone Acetonide | Unidentified Pharmaceutical Company |
| Syntabrax | Chlordiazepoxide; Clidinium Bromide | Synco; Singapore Pharmaceutical |
| Syntac-D | Domperidone; Ranitidine | Synokem Pharmaceuticals |
| Syntam | Piracetam | Synmosa Biopharma Corporation; Zyfas Medical |
| Syntapon | Sodium Lauryl Sulfate | Unidentified Pharmaceutical Company |
| Syntarpen | Cloxacillin | Unidentified Pharmaceutical Company |
| Syntaverin | Metamizole; Pramiverine Hydrochloride | Merck |
| Syntedril | Diphenhydramine | Unidentified Pharmaceutical Company |
| Syntemax | Dexamethasone Sodium Phosphate; Neomycin Sulfate; Polymyxin B Sulfate | Pascual Laboratories; Optaderm Pharma |
| Synterin | Rolitetracycline | Unidentified Pharmaceutical Company |